tiprankstipranks
Trending News
More News >
Pharvaris (PHVS)
NASDAQ:PHVS

Compare Pharvaris (PHVS) vs. Competitors

Compare
162 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Pharvaris
$26.17
$1.67B
-8.91
62.50%
7 Buy
1 Hold
0 Sell
Strong Buy
BioCryst
$9.16
$2.46B
6.20
28.57%
8 Buy
0 Hold
0 Sell
Strong Buy
Celldex
$28.54
$2.00B
-6.98
50.53%
9 Buy
1 Hold
1 Sell
Moderate Buy
Viridian Therapeutics
$27.73
$2.85B
-5.48
80.43%
11 Buy
1 Hold
0 Sell
Strong Buy
Edgewise Therapeutics
$29.69
$3.22B
22.20%
8 Buy
1 Hold
0 Sell
Strong Buy
Biohaven Ltd.
$8.96
$1.35B
-1.64
-68.83%
9 Buy
3 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PHVS
Pharvaris
26.13
10.67
69.02%
BCRX
BioCryst
9.81
2.12
27.57%
CLDX
Celldex
30.03
10.15
51.06%
VRDN
Viridian Therapeutics
27.84
12.52
81.72%
EWTX
Edgewise Therapeutics
30.05
6.23
26.15%
BHVN
Biohaven Ltd.
8.96
-19.22
-68.20%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts